Brisebarre A, Ancel J, Ponchel T, Loeffler E, Germain A, Dalstein V, Dormoy V, Durlach A, Delepine G, Deslée G, Polette M, Nawrocki-Raby B. Transcriptomic FHITlow/pHER2high signature as a predictive factor of outcome and immunotherapy response in non-small cell lung cancer. Front Immunol. 2022 Dec 5;13:1058531. doi: 10.3389/fimmu.2022.1058531. PMID: 36544755; PMCID: PMC9760670.
Scientific activities
The UMR-S 1250 unit is a partner of PRC IRUPP (IRon Uptake Pathways in Pseudomonas aeruginosa: phenotypic switches and mechanism of regulation) at AAPG 2022.
Luczka-Majérus E, Bonnomet A, Germain A, Lalun N, Kileztky C, Perotin JM, Deslée G, Delepine G, Polette M, Dormoy V, Coraux C. Ciliogenesis is intrinsically altered in COPD small airways. Eur Respir J. 2022 Dec 22;60(6):2200791. doi: 10.1183/13993003.00791-2022. PMID: 36396143; PMCID: PMC9772502.
Saber Cherif L, Diabasana Z, Perotin JM, Ancel J, Petit LMG, Devilliers MA, Bonnomet A, Lalun N, Delepine G, Maskos U, Gosset P, Polette M, Muggeo A, Guillard T, Deslée G, Dormoy V. The Nicotinic Receptor Polymorphism rs16969968 Is Associated with Airway Remodeling and Inflammatory Dysregulation in COPD Patients. Cells. 2022 Sep 20;11(19):2937. doi: 10.3390/cells11192937. PMID: 36230899; PMCID: PMC9563397.
The UMR-S 1250 unit is a partner of PRC iREG2 (Immune regulation regeneration) at AAPG 2022.
Babosan A, Skurnik D, Muggeo A, Pier GB, Baharoglu Z, Jové T, Ploy MC, Griveau S, Bedioui F, Vergnolle S, Moussalih S, de Champs C, Mazel D, Guillard T. A qnr-plasmid allows aminoglycosides to induce SOS in Escherichia coli. Elife. 2022 Jan 17;11:e69511. doi: 10.7554/eLife.69511. PMID: 35037621; PMCID: PMC8789287
The UMR-S 1250 unit is a coordinator of PRME STarCilOPD (Screening and targeting of cilia defects in chronic obstructive pulmonary disease) at AAPG 2022.
Perotin JM, Gierski F, Bolko L, Dury S, Barrière S, Launois C, Dewolf M, Chouabe S, Bongrain E, Picard D, Tran E, N'Guyen Y, Mourvillier B, Servettaz A, Rapin A, Marcus C, Lebargy F, Kaladjian A, Salmon JH, Deslee G. Cluster analysis unveils a severe persistent respiratory impairment phenotype 3-months after severe COVID-19. Respir Res. 2022 Aug 2;23(1):199. doi: 10.1186/s12931-022-02111-9. PMID: 35918719; PMCID: PMC9344257.